Exhibit 32.1
                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


          In  connection  with the  Quarterly  Report of  CytoGenix,  Inc.  (the
"Company")  on Form 1O-Q for the period  ended  March 31, 2009 as filed with the
Securities  and Exchange  Commission on the date hereof (the  "Report"),  I, Lex
Cowsert, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906
of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

          (1)The Report fully complies with the requirements of section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

          (2) The information  contained in the Report fairly  presents,  in all
material  respects,  the  financial  condition  and result of  operations of the
Company.


/s/ Lex Cowsert
- ---------------
Lex Cowsert, PH.D.
Chief Executive Officer


May 20, 2009